Clinical Trial Update: CXCR4-targeted PET/CT Imaging in Hematological Malignancies [NA]

View source ↗

Summary

This clinical trial update indicates recruitment is ongoing for a CXCR4-targeted PET/CT imaging agent in hematologic malignancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Cancer

Drugs mentioned

• 68Ga-labeled CXCR4-targeted radiotracer (PET/CT imaging) (CXCR4-targeted radiotracer)

Snippet

Sponsor: Zhongnan Hospital | Conditions: CXCR4, PET/CT | NA | Status: RECRUITING